Sickle cell disease and the kidney

Seminars in Nephrology

Volumn 23, Issue 1, 2003, Pages 66-76

  Scheinman, Jon I ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE ASSOCIATION; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY HYPERTROPHY; KIDNEY MEDULLA; KIDNEY PAPILLA NECROSIS; KIDNEY TRANSPLANTATION; KIDNEY TUBULE DISORDER; MORBIDITY; PERFUSION; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SICKLE CELL ANEMIA; SURVIVAL;

EID: 0037254825     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1053/snep.2003.50006     Document Type: Review

References (66)

1. Scheinman JI: The kidney in sickle cell disease, in Greenberg A (ed): Primer on Kidney Diseases (ed 2). San Diego, CA, Academic Press, 1998, pp 309-313
2. Powars DR, Elliott-Mills DD, Chan L, et al: Chronic renal failure in sickle cell disease: Risk factors, clinical course, and mortality. Ann Intern Med 115:614-620, 1991
3. Platt OS, Brambilla DJ, Rosse WF, et al: Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 330:1639-1644, 1994
4. Sklar AH, Campbell H, Caruana RJ, et al: A population study of renal function in sickle cell anemia. Int J Artif Organs 13:231-236, 1990
5. Falk RJ, Scheinman JI, Phillips G, et al: Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme. N Engl J Med 326:910-915, 1992
6. Powars DR, Meiselman HJ, Fisher TC, et al: β-S gene cluster haplotypes modulate hematologic and hemorheologic expression in sickle cell anemia. Use in predicting clinical severity. Am J Pediatr Hematol Oncol 16:55-61, 1994
7. Guasch A, Zayas CF, Eckman JR, et al: Evidence that microdeletions in the α globin gene protect against the development of sickle cell glomerulopathy in humans. J Am Soc Nephrol 10:1014-1019, 1999
8. Rodriguez-Romero WE, Saenz-Renauld GF, Chaves-Villalobos MA: Haplotipos de la hemoglobina S: Importancia epidemiologica, antropologica y clinica. [Hemoglobin S haplotypes: Their epidemiologic, anthropologic and clinical importance.] Rev Panam Salud Publica 3:1-8, 1998
9. Steinberg MH: Management of sickle cell disease. N Engl J Med 340:1021-1030, 1999
10. Saborio P, Scheinman JI: Sickle cell nephropathy. J Am Soc Nephrol 10:187-192, 1999
11. van Eps S, De Jong PE: Sickle cell disease, in Schrier RW, Gottschalk CW (eds): Diseases of the Kidney. Little, Brown, Boston/Toronto, 1988, pp 2561-2681
12. Bruno D, Wigfall DR, Zimmerman SA, et al: Genitourinary complications of sickle cell disease. J Urol 166:803-811, 2001
13. Allon M: Renal abnormalities in sickle cell disease. Arch Intern Med 150:501-504, 1990
14. Elisaf M, Katopodis K, Siamopoulos KC: Renal abnormalities in sickle-cell β-thalassemia. Am J Hematol 66:68-69, 2001
15. Etteldorf JN, Smith JD, Tuttle AH, et al: Renal hemodynamics studies in adults with sickle cell anemia. Am J Med 25:243-248, 1955
16. Allon M: Renal abnormalities in sickle cell disease. Nephron 150:501-504, 1990
17. Lonsdorfer A, Comoe L, Yapo AE, et al: Proteinuria in sickle cell trait and disease: An electrophoretic. Clin Chim Acta 181:239-248, 1989
18. Bakir AA, Hathiwala SC, Ainis H, et al: Prognosis of the nephrotic syndrome in sickle glomerulopathy. A retrospective study. Am J Nephrol 7:110-115, 1987
19. Guasch A, Cua M, Mitch WE: Early detection and the course of glomerular injury in patients with sickle cell anemia. Kidney Int 49:786-791, 1996
20. Pandya KK, Koshy M, Brown N, et al: Renal papillary necrosis in sickle cell hemoglobinopathies. J Urol 115:497-501, 1976
21. McCall IW, Moule N, Desai P, et al: Urographic findings in homozygous sickle cell disease. Radiology 126:99-104, 1978
22. Walker TM, Serjeant GR: Increased renal reflectivity in sickle cell disease: Prevalence and characteristics. Clin Radiol 50:566-569, 1995
23. Johnson CS, Giorgio AJ: Arterial blood pressure in adults with sickle cell disease. Arch Intern Med 141:891-893, 1981
24. Pegelow CH, Colangelo L, Steinberg M, et al: Natural history of blood pressure in sickle cell disease: Risks for stroke and death associated with relative hypertension in sickle cell anemia. Am J Med 102:171-177, 1997
25. Sklar AH, Perez JC, Harp RJ, et al: Acute renal failure in sickle cell anemia. Int J Artif Organs 13:347-351, 1990
26. Baron BW, Mick R, Baron JM: Hematuria in sickle cell anemia - not always benign: Evidence for excess frequency of sickle cell anemia in African Americans with renal cell carcinoma. Acta Haematol 92:119-122, 1994
27. Davis CJ Jr, Mostofi FK, Sesterhenn IA: Renal medullary carcinoma. The seventh sickle cell nephropathy. Am J Surg Pathol 19:1-11, 1995
28. Davidson AJ, Choyke PL, Hartman DS, et al: Renal medullary carcinoma associated with sickle cell trait: Radiologic findings. Radiology 195:83-85, 1995
29. Avery RA, Harris JE, Davis CJ, et al: Renal medullary carcinoma: Clinical and therapeutic aspects of a newly discribed tumor. Cancer 78:128-132, 1996
30. de Jong PE, Statius van Eps LW: Sickle cell nephropathy: New insights into its pathophysiology. Kidney Int 27:711-717, 1985
31. Zadeii G, Lohr JW: Renal papillary necrosis in a patient with sickle cell trait. J Am Soc Nephrol 8:1034-1039, 1997
32. Chauhan PM, Kondlapoodi P, Natta CL: Pathology of sickle cell disorders. Pathology Ann 18:253-276, 1983
33. Burry A, Cross R, Axelsen R: Analgesic nephropathy and the renal concentrating mechanism. Pathol Ann 12:1-31, 1977
34. Morgan AG, Shah DJ, Williams W: Renal pathology in adults over 40 with sickle-cell disease. Nephron 36:241-250, 1987
35. Verani RR, Conley SB: Sickle cell glomerulopathy with focal segmental glomerulosclerosis. Child Nephrol Urol 11:206-208, 1991
36. De Paepe ME, Trudel M: The transgenic SAD mouse: A model of human sickle cell glomerulopathy. Kidney Int 46:1337-1345, 1994
37. Bunn HF: Mechanisms of disease - pathogenesis and treatment of sickle cell disease. N Engl J Med 337:762-769, 1997
38. Nath KA, Grande JP, Haggard JJ, et al: Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease. Am J Pathol 158:893-903, 2001
39. Nath KA, Vercellotti GM, Grande JP, et al: Heme protein-induced chronic renal inflammation: Suppressive effect of induced heme oxygenase-1. Kidney Int 59:106-117, 2001
40. Bank N, Kiroycheva M, Ahmed F, et al: Peroxynitrite formation and apoptosis in transgenic sickle cell mouse kidneys. Kidney Int 54:1520-1528, 1998
41. Hostetter TH, Olson JL, Rennke HG, et al: Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. Nephron 241:F85-F93, 1981
42. Jennette JC, Charles L, Grubb W: Glomerulomegaly and focal segmental glomerulosclerosis associated with obesity and sleep-apnea syndrome. Am J Kidney Dis 10:470-472, 1987
43. Fogo A, Hawkins EP, Berry PL, et al: Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis. Kidney Int 38:115-123, 1990
44. Chen YT, Coleman RA, Scheinman JI, et al: Renal disease in type I glycogen storage disease. N Engl J Med 318:7-11, 1988
45. Spear GS: The glomerulus in cyanotic congenital heart disease and primary pulmonary hypertension. A review. Nephron 1:238-248, 1964
46. Yoshida Y, Fogo A, Ichikawa I: Glomerular hemodynamic changes vs. hypertrophy in experimental glomerular sclerosis. Nephron 35:654-660, 1989
47. Bhathena DB, Sondheimer JH: The glomerulopathy of homozygous sickle hemoglobin (SS) disease: Morphology and pathogenesis. J Am Soc Nephrol 1:1241-1252, 1991
48. Lande IM, Glazer GM, Sarnaik S, et al: Sickle-cell nephropathy: MR imaging. Radiology 158:379-383, 1986
49. Woolf AS, Fine LG: Do glomerular hemodynamic adaptations influence the progression of human renal disease? Pediatr Nephrol 5:88-93, 1991
50. Vener KJ, Feuer EJ, Gorelic L: A statistical model validating triage for the peer review process: Keeping the competitive applications in the review pipeline. FASEB J 7:1312-1319, 1993
51. Tolaymat A, Al Mousily F, MacWilliam K, et al: Parvovirus glomerulonephritis in a patient with sickle cell disease. Pediatr Nephrol 13:340-342, 1999
52. Khamashta MA, Williams FM, Hunt BJ: Anticoagulation for venous thromboembolism [letter]. N Engl J Med 341:539-540, 1999
53. Simckes AM, Chen SS, Osorio AV, et al: Ketorolac-induced irreversible renal failure in sickle cell disease: A case report. Pediatr Nephrol 13:63-67, 1999
54. Baliga BS, Pace BS, Chen HH, et al: Mechanism for fetal hemoglobin induction by hydroxyurea in sickle cell erythroid progenitors. Am J Hematol 65:227-233, 2000
55. Ferster A, Tahriri P, Vermylen C, et al: Five years of experience with hydroxyurea in children and young adults with sickle cell disease. Blood 97:3628-3632, 2001
56. Wang WC, Helms RW, Lynn HS, et al: Effect of hydroxyurea on growth in children with sickle cell anemia: Results of the HUG-KIDS Study. J Pediatr 140:225-229, 2002
57. Iyamu EW, Fasold H, Roa D, et al: Hydroxyurea-induced oxidative damage of normal and sickle cell hemoglobins in vitro: Amelioration by radical scavengers. J Clin Lab Anal 15:1-7, 2001
58. Foucan L, Bourhis V, Bangou J, et al: A randomized trial of captopril for microalbuminuria in normotensive adults with sickle cell anemia. Am J Med 104:339-342, 1998
59. Tomson CR, Edmunds ME, Chambers K, et al: Effect of recombinant human erythropoietin on erythropoiesis in homozygous sickle-cell anaemia and renal failure. Nephrol Dial Transplant 7:817-821, 1992
60. Rodgers GP, Dover GJ, Uyesaka N, et al: Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease [see comments]. N Engl J Med 328:73-80, 1993
61. Chatterjee SN: National study on natural history of renal allografts in sickle cell disease or trait. Nephron 25:199-201, 1980
62. Ojo AO, Govaerts TC, Schmouder RL, et al: Renal transplantation in end-stage sickle cell nephropathy. Transplantation 67:291-295, 1999
63. Bleyer AJ, Donaldson LA, McIntosh M, et al: Relationship between underlying renal disease and renal transplantation outcome. Am J Kidney Dis 37:1152-1161, 2001
64. Miner DJ, Jorkasky DK, Perloff LJ, et al: Recurrent sickle cell nephropathy in a transplanted kidney. Am J Kidney Dis 10:306-313, 1987
65. Schleuning M, Stoetzer O, Waterhouse C, et al: Hematopoietic stem cell transplantation after reduced-intensity conditioning as treatment of sickle cell disease. Exp Hematol 30:7-10, 2002
66. Scheinman JI: Sickle cell nephropathy, in Barratt TM, Avner EA, Holliday MA (eds): Pediatric Nephrology. Lippincott, Williams & Wilkins, Baltimore, 1999, pp 497-507